Mankind Pharma Q2 profit rises 38% to Rs 716 crore

The Economic Times27 Oct 2026, 07:00 PKTvia NewsData.io

Mankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337.9 crore compared to ₹3,697.2 crore in the same quarter last year. This growth is attributed to strong performance in both domestic and international markets. The recent acquisition of Armed Cell Therapeutics is expected to enhance R&D capabilities.

Read the full story on The Economic Times

Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.